Is BYSI or CANF more undervalued in 2026?

CirclFi compares BeyondSpring, Inc. (BYSI) and Can-Fite Biopharma Ltd (CANF) using 13 institutional-grade valuation models. BYSI has a Quality of Company score of 3.5/10 while CANF scores 2.2/10.

Which is a better buy — BYSI or CANF?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BYSI and CANF valuations compare?

BYSI at $1.72 and CANF at $3.36 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BYSI vs CANF Valuation Comparison 2026 — Intrinsic Value Analysis

BYSI

Biotechnology

BeyondSpring, Inc.

Quality

3.5

out of 10

Value Trap

SAFE

Price

$1.72

Last close

Models

10/13

Active

CANF

Biotechnology

Can-Fite Biopharma Ltd

Quality

2.2

out of 10

Value Trap

SAFE

Price

$3.36

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	BYSI Fair Value	BYSI Upside	CANF Fair Value	CANF Upside
Bayesian DCF	Intrinsic	$3.63	+152.2%	$0.89	-73.5%
Earnings Power Value	Intrinsic	$0.75	-49.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$2.56	+48.6%	$2.83	-15.6%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BYSI vs CANF — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BYSI vs CANF — Which Stock Is More Undervalued?

BYSI scores higher with a 3.5/10 quality rating vs CANF's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BeyondSpring, Inc. (BYSI) and Can-Fite Biopharma Ltd (CANF) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BYSI currently trades at $1.72 with a QOC of 3.5/10, while CANF trades at $3.36 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).